Title:
PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOF
Document Type and Number:
Japanese Patent JP2021119171
Kind Code:
A
Abstract:
To provide antibody-drug conjugates with reduced reversible self-association.SOLUTION: The present disclosure provides compositions comprising (i) antibody-drug conjugates (ADCs) comprising benzodiazepines, and (ii) a small hydrophobic molecule, methods of treatment using the compositions, and methods of formulating the compositions. Furthermore, the present disclosure provides methods of reducing reversible self-association in antibodies and in antibody-drug conjugates.SELECTED DRAWING: Figure 1
Inventors:
BARTLETT ELIZABETH
Application Number:
JP2021075689A
Publication Date:
August 12, 2021
Filing Date:
April 28, 2021
Export Citation:
Assignee:
IMMUNOGEN INC
International Classes:
A61K47/68; A61K9/08; A61K9/19; A61K31/5517; A61K39/395; A61K47/02; A61K47/10; A61K47/12; A61K47/14; A61K47/18; A61P35/00
Domestic Patent References:
JP2014521591A | 2014-08-28 |
Attorney, Agent or Firm:
Osamu Yamamoto
Toru Miyamae
Toru Miyamae
Previous Patent: 3−(3−ジメチルアミノ−1−エチル−2−メチル−プロピル)−フェ...
Next Patent: 嚢胞性線維症膜コンダクタンス制御因子の調節物質、医薬組成物、治療方...
Next Patent: 嚢胞性線維症膜コンダクタンス制御因子の調節物質、医薬組成物、治療方...